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Abstract
The MacBlue transgenic mouse uses the Csf1r promoter and first intron to drive expression of gal4-VP16, which in turn
drives a cointegrated gal4-responsive UAS-ECFP cassette. The Csf1r promoter region used contains a deletion of a 150 bp
conserved region covering trophoblast and osteoclast-specific transcription start sites. In this study, we examined
expression of the transgene in embryos and adult mice. In embryos, ECFP was expressed in the large majority of
macrophages derived from the yolk sac, and as the liver became a major site of monocytopoiesis. In adults, ECFP was
detected at high levels in both Ly6C+ and Ly6C- monocytes and distinguished them from Ly6C+, F4/80+, CSF1R+ immature
myeloid cells in peripheral blood. ECFP was also detected in the large majority of microglia and Langerhans cells. However,
expression was lost from the majority of tissue macrophages, including Kupffer cells in the liver and F4/80+ macrophages of
the lung, kidney, spleen and intestine. The small numbers of positive cells isolated from the liver resembled blood
monocytes. In the gut, ECFP+ cells were identified primarily as classical dendritic cells or blood monocytes in disaggregated
cell preparations. Immunohistochemistry showed large numbers of ECFP+ cells in the Peyer’s patch and isolated lymphoid
follicles. The MacBlue transgene was used to investigate the effect of treatment with CSF1-Fc, a form of the growth factor
with longer half-life and efficacy. CSF1-Fc massively expanded both the immature myeloid cell (ECFP2) and Ly6C+ monocyte
populations, but had a smaller effect on Ly6C2 monocytes. There were proportional increases in ECFP+ cells detected in
lung and liver, consistent with monocyte infiltration, but no generation of ECFP+ Kupffer cells. In the gut, there was selective
infiltration of large numbers of cells into the lamina propria and Peyer’s patches. We discuss the use of the MacBlue
transgene as a marker of monocyte/macrophage/dendritic cell differentiation.
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Introduction
The mononuclear phagocyte system is a family of cells
comprising progenitors in the bone marrow (BM), circulating
monocytes and tissue macrophages [1,2]. The proliferation,
differentiation and survival of many of these cells depends upon
macrophage colony-stimulating factor (CSF1) which mediates its
effects through the protein tyrosine kinase receptor, CSF1R [3–5].
Although Csf1r mRNA is expressed in all myeloid cells, the
protein product is present at high levels only in mononuclear
phagocyte system (MPS) lineage cells [6]. A Csf1r-EGFP (Mac-
Green) transgene described previously perfectly recapitulates the
location of Csf1r mRNA and provides a marker for MPS cells in
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tissues [7]. Recent studies of inbred mice have questioned the role
of monocytes as immediate precursors for the maintenance of
tissue macrophage numbers [8–10] but regardless of their origin,
the effects of a blocking antibody against the CSF1R supports the
concept that macrophage survival/replacement in most tissues
requires continuous CSF1R signalling [11].
CSF1-dependent macrophages have been ascribed many roles
in tissue repair and homeostasis [4,5]. Recombinant CSF1 has
been tested in clinical trials for several indications [4], but has not
yet found a clinical application. CSF1 has a very short half-life in
the circulation of mice (1.6 hours), being cleared from the
circulation by CSF1R mediated internalization and degradation
by Kupffer cells of the liver [12]. Renal excretion becomes the
major mechanism of clearance when the receptor-mediated
clearance is saturated. The 150 amino acid active CSF1 protein
produced in bacteria is well below the renal clearance threshold of
around 68 kDa (the size of albumin), and consequently the
majority of any injected bolus dose is rapidly cleared by the
kidney. Recent studies have reinvigorated interest in CSF1 as a
therapeutic agent in tissue repair [13–17]. To enable reinvestiga-
tion of therapeutic applications of CSF1, we have increased the
half-life by producing a conjugate of pig CSF1 (which is active in
mice; [18]) with the Fc region of immunoglobulin [19].
The 7.2 kb Csf1r region from the MacGreen transgene contains
3.5 kb of Csf1r promoter, the first intron including the critical
FIRE element [20] and part of the second exon linked to a EGFP
reporter [7]. In peripheral blood [21], and amongst inflammatory
populations [22], EGFPhi and EGFPlo myeloid cell populations
can be distinguished. The MacGreen transgenic construct also
expresses in trophoblasts, which utilise transcription start sites
(TSS) within a 150 bp conserved region upstream of the major
macrophage TSS cluster. To eliminate trophoblast expression, we
removed the 150 bp conserved region. This deletion abolished
expression in both EGFPlo myeloid cell populations and in
osteoclasts (OCL). The latter cells were found to utilise additional
TSS within the deleted region [23]. We used the MacGreen
transgene, with the 150 bp internal deletion, to create a binary
transgene, in which the Csf1r promoter driving the transcription
factor, gal4-VP16, is cointegrated with a Gal4-responsive UAS-
CFP cassette to produce the MacBlue transgenic line [24]. This
approach was derived from genetic studies in drosophila; the
principle being that the ‘‘driver’’ line (in this case expressing in
macrophages) can be crossed to a target line, in which a UAS
sequence is placed upstream of a gene of interest. Crossing this line
to a UAS-Schlafen4 transgenic line produced expression of
Schlafen4 in macrophages that also expressed ECFP, and
produced a myeloproliferative disorder [25]. The MacBlue
transgene expression was detected in embryonic macrophages, in
blood monocytes, microglia and Langerhans cells, interdigitating
cells (classical DC) in spleen and in BM-derived macrophages [25].
In a recent study, the MacBlue transgene was used to monitor the
trafficking of blood monocytes from the BM [26]. The line was
crossed to a CX3CR1gfp/+ transgene to study the effect of
CX3CR1 in monocyte mobilisation. In CX3CR1gfp/+ mice, the
EGFP was detected in large stellate macrophages in the BM,
whereas ECFP in the MacBlue mice was more restricted to
monocyte-like rounded cells [26]. This study provided the first
indication that the ECFP in the MacBlue line was not universally
expressed by tissue macrophages. Here we report the surprising
finding that the majority of adult tissue macrophages do not
express detectable ECFP in the MacBlue transgenic mice, but
expression is retained on monocytes and classical DC. The
MacBlue transgene thus provides a novel marker for study of
monocyte and DC trafficking and mononuclear phagocyte
development in tissues.
Results
The distribution of ECFP-positive cells in the tissue of the
MacBlue mouse
The 150 bp deletion of a distal promoter region of Csf1r used in
the MacBlue ECFP transgene (and the equivalent deletion in the
MacGreen) ablates expression in granulocytes, as well as
trophoblasts and osteoclasts [23–25]. During embryonic develop-
ment, ECFP+ cells in the MacBlue line first appeared in the yolk
sac, and subsequently throughout the embryo [24,25]. We have
examined the appearance of the ECFP+ cells during embryogen-
esis in greater detail (Figure 1). ECFP was detectable at high levels
in the abundant decidual macrophages (Fig 1A). In view of
evidence of an early wave of maternal-derived macrophages
during fetal development [27], we examined embryos in which the
MacBlue transgene was paternally-derived. The first detectable
ECFP+ cells were observed in Reichert’s membrane (Fig 1B) with
occasional cells visible in the yolk sac around 8dpc. Thereafter, the
ECFP marker provided a striking view of the progressive
infiltration of the embryo by macrophages, including the onset
of haemopoiesis in the liver and areas of apoptosis surrounding the
pharyngeal arches (Figs 1C and 1D).
Expression of the MacBlue transgene was previously detected in
BM-derived macrophages grown in CSF1, and at high levels in
whole mounts of spleen and in Langerhans cells, which can be
imaged directly in the ear skin using confocal microscopy [24].
None of the previous studies reported expression in adult organs
other than spleen. Lamina propria macrophages are probably the
largest pool of macrophages in the body, and in adults are
replenished continuously from a Ly6C+ monocyte progenitor
[28,29]. They are rapidly and completely depleted by anti-CSF1R
treatment [21]. To our surprise, examination of sections indicated
that the lamina propria myeloid populations were almost
completely devoid of ECFP expression in the MacBlue mouse.
Figure 2 shows en face views of the small intestinal walls of the
MacGreen and MacBlue mice. Whereas the MacGreen transgene
highlights the high concentration of CSF1R-dependent macro-
phages in the villi in the small intestine, and also the concentration
of phagocytic cells underlying the dome epithelium of the Peyer’s
patch, the MacBlue transgene was detectable only in occasional
cells in each villus. Interestingly, ECFP+ cells were concentrated
beneath the epithelia of Peyer’s patches and also in isolated
lymphoid follicles, and enabled visualization of these structures in
whole mounts. The expression of ECFP in the lymphoid follicles is
consistent with its expression by interdigitating cells of the spleen
[24].
As noted above, ECFP is expressed by Langerhans cells. These
cells are also associated with stratified squamous epithelium of the
oral and nasal cavity and oesophagus [30]. The ECFP marker also
provided a striking marker for a population of stellate cells within
the submucosa and muscularis in this site and highlighted the
nasal-associated lymphoid tissue (Figure S1).
To determine exactly which cells expressed ECFP, we next
examined small intestinal and colonic isolates obtained by
enzymatic digest using multi-parameter flow cytometry (Figure 3).
Consistent with the microscopy, ECFP+ cells were relatively rare
in the steady state mucosa, comprising 4.660.7% and 5.862.06%
of total live CD45+ leukocytes in the small intestine and colon
respectively (Fig 3A). The vast majority of ECFP+ cells expressed
both CD11c and MHCII in both parts of the intestine (Fig 3B).
Given that both conventional migratory DC and tissue resident
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intestinal macrophages in the intestine express CD11c and
MHCII, we next used expression of CD45, CD11b, F4/80,
CD11c, Ly6C and MHCII to identify DC and monocyte/
macrophage subsets to assess their expression of ECFP. Amongst
the CD45+ CD11b+ F4/80+ compartment, four populations of
cells could be identified on the basis of Ly6C and MHCII
expression. F4/80+ CD11b+ cells lacking expression of Ly6C and
MHCII (G1 cells) are eosinophils which display high SSC
characteristics [31] and as expected, these were uniformly negative
for ECFP expression (Fig 3C). Ly6ChiMHCII2, Ly6C+MHCII+
and Ly6C2MHCII+ myeloid cells (denoted G2, G3 and G4
respectively) represent a monocyte to macrophage differentiation
continuum in the intestinal mucosa [28,29]. The majority of the
G2 cells (Ly6ChiMHCII2 monocytes) expressed ECFP (60% in
the small intestine, and 70% in colon, Fig 3C), in keeping with
analysis of blood Ly6Chi monocytes (see below). Similarly most
Ly6C+MHCII+ (G3) cells (52.8610.9%) expressed ECFP at high
levels, whereas few (,10%) of F4/80hiMHCII+Ly6C2 (G4)
mature macrophages retain ECFP.
We next examined the expression of ECFP amongst the CD45+
CD11c+ MHCII+ F4/802 population considered classical DC
[32]. Around ,40% of this entire population expressed ECFP
(Fig 3D). The intestinal DC pool can be segregated into four
discrete populations based on the expression of CD103 and
CD11b, all of which have been reported to express the DC-
associated transcription factor Zbtb46 [33]. The majority of ECFP
expression is attributable to the CD1032 DC subsets, which
contained 60–80% ECFP+ cells amongst the CD1032CD11b+
and CD1032CD11b2 DC subsets in both tissues. The
CD103+CD11b+ DC subset also showed significant ECFP
expression with ,25% of cells positive in small intestine and
55% in colon, whereas fewer CD103+CD11b2 DC expressed
ECFP. All populations also showed a gradient of expression, rather
than a sharp peak, suggesting a progressive loss (Figure S2).
Given this pattern of expression, we looked at the corresponding
DC subsets in the draining mesenteric lymph node (MLN), using
the expression levels of MHCII to define LN-resident (MHCII+)
and migratory (MHCIIhi) DC. The expression of ECFP was much
lower in the MLN compared with the mucosa. Whereas
approximately one quarter of LN-resident CD11b+ DC expressed
ECFP, of the migratory DC only ,10% of CD103+ CD11b+ and
CD1032CD11b+ DC had detectable ECFP, and then only at very
low levels compared to the cells in the lamina propria; CD103+
Figure 1. Expression of the MacBlue transgene in the mouse embryo. Embryos and the surrounding membranes were dissected and viewed
by fluorescent microscopy. (A) E8.5 decidua from a ECFP+ female. The following ECFP expression was paternally derived: (B) E8.5 Reichert’s
membrane, (C) E9.5 embryo and (D) E11.5 embryo. PA: pharyngeal arches.
doi:10.1371/journal.pone.0105429.g001
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CD11b2 DC were completely devoid of any ECFP expression (Fig
S2).
Consistent with our findings in the gut, there were very few
ECFP+ cells in liver, kidney and lung compared to the abundant
macrophage populations identified with the MacGreen transgene
[7] (see also image database on www.macrophages.com). We
disaggregated the liver and examined cells of the monocyte/
macrophage lineage for the expression of ECFP (Figure 4). The
F4/80hi CD11blo Kupffer cells, which are uniformly EGFP+ in the
MacGreen mice [7], were devoid of ECFP expression. All ECFP+
cells expressed lower levels of F4/80 and high levels of CD11b and
had similar distributions of Ly6C+ and Ly6C2 subpopulations to
blood monocytes. Accordingly, we consider that these are blood-
derived cells, either migrating in the parenchyma, or trapped in
the vessels despite the exsanguination.
The MacGreen reporter is expressed in microglia, but is not
detected in neuronal cells [7]. Like Langerhans cells, microglia
have been reported to be dependent in part upon the alternative
CSF1R ligand, interleukin 34 [34]. A recent report suggested that
CSF1R can be expressed by neurons, is induced in response to
tissue damage, and can mediate trophic effects of CSF1 via direct
effects on neurons [16]. The MacBlue ECFP marker was found to
be a very effective marker of microglia because the very bright
fluorescence and negligible autofluorescence highlights their fine
processes. Figure 5A shows a section of the pyramidal layer of the
hippocampus of the MacBlue mouse, co-stained for the neuronal
marker, NeuN. Occasional ECFP+ cells were seen within the
pyramidal layer, but they were not NeuN-positive, and had the
distinguishing ramified processes characteristic of microglia. To
determine whether ECFP was expressed by all microglia, we
performed a comparative analysis on disaggregated whole brain
from the MacBlue and MacGreen mice. All CD11b+CD45lo cells
also expressed F4/80 (data not shown). At least 95% of microglia
were detected with the EGFP transgene. With ECFP, the
distribution was less clearcut, and varied between preparations
from 60–80%. The analysis is complicated by a higher level of
autofluorescence in the ECFP channel in microglia. The
fluorescence showed a rather broad distribution, suggesting that
it could be progressively lost (Fig 5B).
The effect of CSF1 treatment on ECFP+ monocyte and
macrophage numbers
Blood monocyte numbers are massively increased in response to
administration of CSF1 [35]. CSF1 also controls the maturation of
blood monocytes [10,11] and their infiltration into tissues and the
proliferation of tissue macrophages [36]. Bone marrow-derived
macrophages grown in CSF1 also expressed the ECFP transgene
[24]. We have recently described a novel CSF1-Fc conjugate that
is more active than the native molecule due to its longer circulating
half-life [19]. We therefore reexamined the distribution of the
MacBlue transgene and relevant subset markers in the blood of
control and CSF1-Fc-treated MacBlue mice (Figure 6). The
administration of CSF1-Fc to MacBlue mice increased the total
number of ECFP+ cells in the peripheral blood from 5.6461% to
34.863.8%. Although both Gr1+(Ly6C/G+) and Gr12 subsets
were increased, the former were increased disproportionately
(Fig 6A). The large majority of the ECFP+ cells expressed the
macrophage marker F4/80 (Fig 6B) and CSF1R (CD115)
(Fig 6C). Note that the CSF1-Fc had only a marginal impact on
the proportions of Gr1+ECFP2 cells. We also identified ECFP2
cells that were positive for F4/80 (Fig 6B) and a smaller subset
expressing CD115 (Fig 6C, upper left quadrant). The CD115+
cells were also expanded around 4-fold in the blood of CSF1-Fc
treated mice (Fig 6C).
Consistent with the reported ability to promote monocyte
infiltration, in the CSF1-Fc-treated mice, there was substantial
infiltration of most tissues by ECFP+ cells. Figure 7 shows the liver
(Fig 7A) and lung (Fig 7B). In the lamina propria of the gut, there
was a massive infiltration of the sub-epithelial dome region of the
Peyer’s patch by ECFP+ cells in the CSF1-Fc-treated mice
(Fig 7C). Increased numbers of positive cells were also seen within
the villi.
Tumour-associated macrophages
Our earlier studies demonstrated that anti-CSF1R treatment
does not alter the recruitment of monocyte macrophages into
inflammatory sites, but does greatly reduce the large numbers of
tumour-associated macrophages (TAMs) detected using the Mac-
Green transgene [11]. We speculated that the MacBlue transgene
would enable live imaging of monocyte infiltration in tumours. To
enable the use of the MacBlue transgene in tumour biology, we
bred it to the FVB background, where we have an established
model of squamous cell carcinoma which attracts very large
numbers of TAMs [37,38]. Figure 8 shows representative FACS
profiles of the purified TAMs, and an intravital image of their
location within established tumours, revealing their close associ-
ation with the vasculature. Analysis of surface markers of
disaggregated leukocytes reveals that ECFP is expressed by only
Figure 2. The expression of MacBlue and MacGreen transgenes
in the small intestine. En face view of the small intestine of a
MacBlue and a MacGreen mouse. White arrows indicate isolated
lymphoid follicles (ILF) in the MacBlue, yellow arrow indicates dome
region of a Peyer’s patch in the MacGreen. The large numbers of EGFP+
macrophages in the lamina propria highlight the individual villi in the
lower image.
doi:10.1371/journal.pone.0105429.g002
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Figure 3. The expression of MacBlue transgenes in the small intestine and colon. Small intestinal and colonic isolates from MacBlue mice
were obtained by enzymatic digest and analysed using multi-parameter flow cytometry. (A) ECFP expression in the small intestine and colon (gated
on live CD45+ cells). (B) Representative FACS plots showing CD45, ECFP, CD11c and MHCII expression in the small intestine and colon of MacBlue
mice. (C) Live CD45+CD11b+F4/80+CD11c2 cells were split into 4 gates based on Ly6C and MHCII expression. The percentage of ECFP+ cells within
these 4 gates was examined. (D) The upper FACS plots display representative percentages of ECFP+CD11c+ cells in the small intestine and colonic
isolates. Live CD45+CD11c+MHCII+F4/802 cells were split into 4 regions based on CD103 and CD11b expression. The percentage of ECFP+ cells within
these 4 regions was examined.
doi:10.1371/journal.pone.0105429.g003
Figure 4. The expression of MacBlue transgenes in the liver. Following digestion of the liver and removal of hepatocytes, cells were examined
for ECFP and F4/80 expression in wild type and MacBlue mice (A). F4/80+ECFP2 (red gate) and F4/80+ECFP+ (blue gate) populations were then
examined for CD11b and Ly6C expression (B).
doi:10.1371/journal.pone.0105429.g004
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around 10% of the CD11b+, F4/80+ macrophages derived from
the tumour.
Summary
The MacBlue transgene is expressed in the earliest macrophage
lineage cells in the embryo, and in foetal liver. In adults, the ECFP
expression is retained only in blood monocytes, many classical
DC, and in a small subset of MPS cells that have been reported to
be established from embryonic sources (microglia, Langerhans
cells, lung macrophages).
Discussion
The conserved upstream region of the mouse Csf1r promoter
contains TSS that are utilised by placental trophoblasts [7]. These
sites are not used in humans, or larger mammals, which initiate
transcription in placenta from a distal promoter 20 kb upstream in
the 39UTR of the PDGFR locus [39]. So placental transcription is
unlikely to be the reason for their conservation. When the
upstream promoter element was deleted in Csf1r-EGFP reporter
mice, expression was ablated in trophoblasts, but also in OCL
[23]. In the current study, we have recognised that the deletion
also abolished expression in mature macrophages in many organs.
This pattern clearly distinguished tissue macrophages in the adult
from those in the developing embryo, where the transgene was first
detected in the yolk sac and Reichert’s membrane macrophages,
and then expressed in foetal liver and in tissue macrophages until
mid-development (Fig 1). Some recent data suggests that tissue
macrophages in the adult can derive from yolk sac progenitors [8–
9]. If this is indeed the case, the MacBlue transgene must be
switched off in the tissue macrophages of the adult at some time
late in gestation or after birth, since it is clearly strongly-expressed
in embryonic tissue macrophages derived from both yolk sac and
liver (Fig 1). Alternatively, it could provide a marker for a
transition in the origin of tissue macrophages late in gestation.
That possibility is the subject of ongoing investigation. The
macrophages in the adult all express Csf1r mRNA, and are
labelled with the intact Csf1r transgene in the MacGreen mouse.
One feature that the MacBlue ECFP+ cells share is that they are
the macrophage population that is largely retained in the CSF1-
deficient op/op mouse [40]. So, one may consider the MacBlue
transgene a novel marker for the CSF1-independent macrophage
population.
Why should deletion of the distal promoter lead to a selective
loss of expression in CSF1-dependent macrophages? Previous
detailed in vivo foot printing analysis during macrophage
differentiation did not extend to this region [41]. Analysis of
human macrophages suggests there is significant protection from
UV irradiation within the distal element [42]. Chromatin IP data
reveals overlapping H3K4Me2 and H3K27 acetylation binding,
indicate of active enhancers, extending through this region
upstream of the macrophage TSS in thioglycollate-elicited murine
macrophages [43]. The distal segment contains the elements
required for growth factor-inducible expression of reporter genes
in non-macrophage tumour cell lines, including signaling by
ectopically-expressed CSF1R [44]. The most obvious explanation
lies with the AP1 motif (TGACTCA in mice), which is conserved
across mammals [23]. Nuclear AP1 activity is induced by CSF1
[45]. The AP1-binding transcription factor, c-jun, interacts
specifically with PU.1 to promote macrophage differentiation
and expression of other macrophage-specific genes ([46] and
references therein) and jun kinase is required for CSF1-dependent
macrophage survival [47]. Resident tissue macrophages express
very high levels of Csf1r mRNA, and constantly internalize and
degrade both ligand and receptor [12]. Csf1r mRNA transcription
in BM-derived macrophages is repressed by CSF1, acting in part
upon runx1 and the FIRE element within the first intron [48]
which also contains a conserved and critical AP1 site [20]. Taking
all of these data together, we speculate that the distal element is
required to sustain Csf1r transcription in the presence of CSF1 in
cells that depend upon CSF1 signaling for survival.
Langerhans cells and microglia are significantly reduced in the
IL34 knockout mouse, in the latter case reflecting the region-
specific expression of CSF1 and IL34 [49]. The view that
microglia derive exclusively from yolk sac-derived progenitors
early in development [50] has been widely-accepted although it
contradicts much earlier studies of the origins of microglia in the
brain [51] and retina [52] which demonstrated substantial
infiltration of monocytes from the blood in the perinatal period
in response to successive waves of cell death. In this respect,
microglia may resemble Langerhans cells, the other macrophage
population depleted in the IL34 null mouse [34]. The Langerhans
Figure 5. The expression of MacBlue and MacGreen transgenes in the brain. PFA-fixed cryosections from MacBlue mice were
immunostained to detect a neuronal marker, neuN (red) in the hippocampus of the brain (A). Microglia demonstrate the ECFP reporter transgene. A
representative6400 z stack projection is shown. (B) Whole brains were digested and analysed for CD11b and transgene expression. Cells were gated
on CD11b+CD45lo.
doi:10.1371/journal.pone.0105429.g005
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cells of the skin appear early during embryonic development, but
are mainly replaced by foetal liver-derived cells [53,54].
Langerhans cells also retain the ECFP marker [24].
The largest F4/80+ macrophage population in the body is in the
wall of the gut [55]. Classical DC from the intestine; F4/802FcR2
cells defined by their ability to stimulate in an allogeneic mixed
lymphocyte reaction, are a very minor subpopulation of the cells
released by enzymatic disaggregation of the lamina propria [56].
There was a period of confusion about their identity derived from
equating CD11c+ cells with DC [57]. CD11c is expressed on the
large majority of myeloid cells in the lamina propria. Cells isolated
by enzymatic digestion are a complex mixture, indeed the
numbers of subsets that have been defined appears to be a
function of the number of markers [58]. The ECFP+F4/
802MHCII/CD11chi ‘‘DC’’ that we observed amongst cells
obtained by enzymatic disaggregation of the wall of the gut have
been further subdivided based upon expression of CD11b and
CD103 [59–61]. At least some of the cells in these populations
expressed the MacGreen Csf1r-EGFP transgene and CSF1R
[59,60], although relatively few CD103+ cells expressed the EGFP
reporter. The MacBlue ECFP marker enables visualization of the
distribution of the classical DC. Bogunovic et al. concluded
previously that the majority of CD103+, CD11b2migratory ‘‘DC’’
derived from lymphoid tissue [59]. The distribution of the
MacBlue transgene, combined with the FACS data, suggests that
this is true for most of the classical DC in the wall of the gut,
although the CD103+ cells might, like the macrophages from the
lamina propria, down-regulate ECFP expression with time. The
concentration of ECFP+ classical DC within isolated lymphoid
follicles is consistent with immunohistochemical detection of
CD11chi, F4/802 cells within these structures[62,63]. The
majority of Zbtb46-EGFP expressing cells in the gut wall are also
found in Peyer’s patches and isolated lymphoid follicles [33,64].
The vast majority of the myeloid cells in the lamina propria,
detected with the MacGreen EGFP transgene, but not the
MacBlue ECFP, are also clearly F4/80+, MHCIIhi [56] and
Figure 6. The expression of MacBlue transgenes in the blood of mice injected with CSF1-Fc. Male and female MacBlue 8–15 weeks old
were injected subcutaneously with either PBS or 1mg/Kg porcine CSF1-Fc for 4 days prior to sacrifice on day 5. Blood was analysed via FACS for ECFP
expression in conjunction with (A) Gr1, (B) F4/80 and (C) CD115 (CSF1R). Representative FACS plots are shown.
doi:10.1371/journal.pone.0105429.g006
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CSF1R-dependent [21] macrophages. They may have important
localized functions in immunosuppression [65] and oral tolerance
[66,67].
The detailed analysis of peripheral blood in the MacBlue
transgenic line (Fig 6) highlighted populations of cells that have
commonly been overlooked in studies of monocyte biology. Mouse
peripheral blood monocytes have been divided into two subsets
based upon expression of the surface marker Ly6C, and the
chemokine receptors CCR2 and CX3CR1 [68]. The populations
also differ in the level of expression of F4/80 [21,69]. Several lines
of evidence indicate that these populations represent a differen-
tiation series controlled by CSF1R signaling. Both of these
populations express the MacGreen transgene in peripheral blood
[21]. Also within MacGreen peripheral blood, there are EGFPlo
cells with substantially lower expression of F4/80 [21]. These cells
were also evident in inflammatory exudates with foreign bodies or
thioglycollate [21,22] but expression was abolished when the
150bp upstream element is removed [23]. Isolation of EGFPlo cells
in inflammatory exudate revealed heterogeneous leukocytes with
ring-shaped nuclei [22]. Others have noted that in terms of surface
markers and morphology, such cells defy classification into
granulocyte and monocyte subclasses [70]. They have some
overlap with myeloid-derived suppressor cells [71] and a subset
could include mobilized, Ly6C+, committed monocyte progenitors
[72]. CSF1-Fc most likely promotes proliferation, differentiation,
maturation and egress of cells from the BM at multiple stages of
derivation from a pluripotent stem cell. In this respect, CSF1-Fc
has effects in common with Progenipoietin (Flt3L/G-CSF) [69].
An earlier study of the response to a single dose of CSF1 in rats
also concluded that the factor promotes release from the BM of
monoblasts and pro-monocytes, and caused a monocytosis and
neutrophilia [73]. CSF1 is also required for the transition from
Ly6C+ to Ly6C2 monocytes [10]. Continued CSF1 signalling is
not required for the production of blood monocytes but is clearly
able to increase conventional monocyte numbers and can direct
stem cell commitment [74].
The relative absence of detectable ECFP in most tissue
macrophages of the MacBlue mouse, and also in the tumour-
associated macrophages, where it is present on blood monocytes
(including those within the tissues) could mean either that (a) the
ECFP is rapidly extinguished as cells differentiate to become tissue
macrophages or (b) the monocytic precursors of tissue macro-
phages are actually the F4/80+, CSF1R+ immature myeloid cells
which lack ECFP (and which are also the precursors of mature
monocytes) or (c) the tissue macrophages are maintained entirely
by self-renewal. In the lamina propria of the intestine we do see
evidence of heterogeneous expression of the MacBlue transgene
(Fig 3), consistent with progressive loss from monocytes entering
the tissue. In other tissues, macrophage populations may turn over
more slowly, and/or down-modulate the EFCP more rapidly, so
the lack of expression of ECFP cannot distinguish the models
above. Tissue macrophages require continuous CSF1R signaling
[21] and can proliferate in response to excess CSF1 [36].
Interpretations of recent data do not take account of the
homeostatic role of CSF1. So, for example, the fact that monocyte
depletion does not produce depletion of tissue macrophages [75]
Figure 7. The expression of MacBlue transgenes in organs of mice injected with CSF1-Fc. Male and female MacBlue 8–15 weeks old were
injected subcutaneously with either PBS or 1 mg/Kg porcine CSF1-Fc for 4 days prior to sacrifice on day 5. Perfusion fixed tissues were examined via
confocal microscopy for ECFP expression. Representative images are shown. (A) liver, (B) lung and (C) lamina propria. White arrow: villi. Red arrow:
sub-epithelial dome region of Peyer’s Patch.
doi:10.1371/journal.pone.0105429.g007
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could simply mean that there is a mechanism of compensation via
elevation of CSF1. What is clearly the case is that the MacBlue
transgene provides a unique marker for the study of macrophage
and DC biology including live imaging of processes of monocyte
extravasation and migration and the response to CSF1 adminis-
tration.
Materials and Methods
Mice
The Csf1r-Gal4VP16/UAS-ECFP+ (MacBlue) and Csf1r-
EGFP+ (MacGreen) mice were bred, genotyped and obtained
from The Roslin Institute Biological Research Facility. MacBlue
mice were also bred onto a pure FVB background at the
University of Edinburgh Biological Research Facility. Approval
was obtained from The Roslin Institute and The University of
Edinburgh Animal Welfare and Ethical Review Body. The
experiments were carried out under the authority of a UK Home
Office Project Licence under the regulations of the Animals
(Scientific Procedures) Act 1986. Endotoxin-free porcine CSF1-Fc
fusion protein was produced as described in detail elsewhere [19].
Male and female MacBlue mice (n = 16); 8–15 weeks old were
injected subcutaneously with either PBS or 1 mg/Kg porcine
CSF1-Fc for 4 days prior to sacrifice on day 5. Blood was collected
by cardiac puncture or mice were perfused fixed with 4%
paraformaldehyde.
Embryo dissection and imaging
Embryos from timed matings were dissected using standard
techniques as described in [76] and imaged using a StereoLumar
v12 (Zeiss) microscope with ECFP and UV filters.
Intestine imaging
Post euthanasia, ileal intestinal sections were excised, cut
longitudinally and washed vigorously with ice cold PBS to remove
all faecal matter and mucus. Sections were then whole-mounted
onto slides with DAKO fluorescent mounting medium and tiled
images of the en face view were visualised using a LSM710 (Zeiss)
confocal microscope.
FACS analysis of small intestine and colon
Lamina propria cells were obtained from adult mouse intestines
by enzymatic digestion as described previously [28,61]. Cells were
isolated from mesenteric lymph nodes by enzymatic digestion with
Figure 8. The expression of MacBlue transgenes in tumour associated macrophages. (A) Squamous cell carcinoma (SCC) tumours grown
on the MacBlue mouse were removed, disaggregated and stained with CD45, CD11b, and F4/80 antibodies. FACS analysis of the resulting population
using the gating shown was used to investigate the expression status of ECFP and F4/80 in the CD45+CD11b+ population. Results shown are
representative of three tumours from three different animals. (B) Representative stitched confocal image of four adjacent images acquired through a
dorsal skinfold window on an anesthetized mouse. Macrophages labelled with ECFP under the control of the Csf1r promoter were observed to
infiltrate throughout the GFP-labelled SCC tumours. Blood vessels are outlined with a white dashed line. Scale bar 30 mm. Images representative of at
least 5 separate tumours.
doi:10.1371/journal.pone.0105429.g008
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1 mg/ml collagenase D (Roche) in calcium magnesium free (CMF)
Hank’s balanced salt solution (HBSS; Gibco, Invitrogen) for 45
minutes. After isolation, cells were passed through a 100 mm and a
40 mm filter before use (Corning).
For flow cytometric analysis of cells, 2–36106 cells were added
to polystyrene tubes (BD Falcon), washed in ice cold FACS buffer
(1 mM EDTA/2% FCS/PBS) and then incubated for 15 mins
with purified anti-CD16/CD32 (Biolegend) to reduce non-specific
binding via Fc receptors, then incubated with the following anti-
mouse antibodies: rat CD45 (30-F11), hamster CD11c (N418), rat
CD11b (M1/70), hamster CD103 (2E7; all Biolegend) and rat F4/
80 (BM8), rat MHCII (M5/114.15.2) and rat Ly6C (HK1.4; all
eBioscience). Cells were then washed in ice cold FACS buffer
before analysis on a LSRII flow cytometer (BD Biosciences). Dead
cells were excluded by including 7-aminoactinomycin D (Biole-
gend) in all staining panels. All data generated was analysed using
FlowJo software (Tree Star Inc, OR, USA).
Liver FACS analysis
Livers from Schedule 1 euthanized mice were digested in 2 mg/
ml collagenase D (Sigma Aldrich) at 37uC for 30 min then passed
through a 100 mm filter. Cells were centrifuged for 7 min at 506g
to remove hepatocytes. Further purification of nonparenchyaml
cells was performed using a 30% percoll (Sigma Aldrich) gradient.
Cells were stained with fixable viability dye eFluor 780 then
incubated with Fc block (TrustainfcX, Biolegend) prior to staining
with rat F4/80 (BM8, Biolegend), rat CD11b (M1/70.15,
Invitrogen) and rat Ly6C (HK1.4, Biolegend). Flow cytometry
performed using the LSR Fortessa and analysed using FloJo.
Imaging of MacBlue mouse brains
For detection of microglia in the brain, 20 mm coronal brain
sections were cut on a freezing sledge microtome and stored in
cryoprotectant buffer (ethylene glycol and glycerol in phosphate
buffer) at220uC. For immunofluorescence staining, tissue sections
were blocked with 5% normal donkey serum (Vector Labs, UK) in
0.3% triton/PBS for 1 hour. Sections were incubated with NeuN
[1:500] (Abcam) overnight at 4uC. The sections were washed
before incubation with secondary antibodies conjugated with
Alexa647 [1:500] (LifeTech) for 2 hours at room temperature.
Sections were mounted on to gelatin coated slides and cover-
slipped using ProLong Gold anti-fade reagent (LifeTech). Fluo-
rescent images were taken using the LSM710 (Zeiss) confocal
microscope and Zeiss Zen software.
FACS analysis of MacBlue and MacGreen mouse brains
MacBlue and MacGreen mice were transcardially perfused with
0.9% saline and brain were removed and digested at 37uC for 1 h
in an enzymatic cocktail consisting of 1x HBSS, 50 U/ml
collagenase D, 100 mg/ml Na-Tosyl-L-lysine chloromethyl ketone
hydrochloride, 5 U/ml DNase I and 8.5 U/ml dispase. The tissue
was then manually homogenised using a Dounce homogeniser.
Myelin was removed after centrifugation of the homogenate on a
35% percoll (GE Healthcare) gradient. The resulting single cell
suspension was incubated with 1 mg/ml anti-CD16/CD32
(Biolegend) before staining with a cocktail containing rat CD11b
(M1/70 1:500, Biolegend), rat CD45 (30-F11 1:200, Biolegend)
and rat F4/80 (BM8 1:200, eBioscience). Flow cytometry was
performed using a BD Fortessa and data was analysed using
FlowJo V10 software.
FACS analysis of blood from CSF1-Fc treated mice
100 mL of anti-coagulated (EDTA) whole blood was incubated
with the appropriate antibody or isotype control in the dark at
room temperature for 30 min: rat F4/80 Biolegend BM8 1:200,
rat Ly-6G/Ly-6C (Gr-1) Biolegend RB6-8C5 1:200, rat CD115
(CSF1R) eBioscience AFS98 1:1000, or Rat IgG2b, k Isotype Ctrl
Biolegend RTK4530 1:200). Blood was processed using DAKO
Uti-lyse, erythrocyte lysing reagent (S3325) according to manu-
facturer’s protocol. Samples were analyzed on BD LSR Fortessa
(blood) and analysed using Summit 4.1 software (DAKO).
Imaging tissues from MacBlue mice treated with CSF1-Fc
Tissues from perfused fixed MacBlue mice were placed into 4%
PFA for 2 hours followed by overnight incubation in 18% sucrose
at 4uC. The following day, tissues were embedded in Tissue-Tek
OCT compound and snap frozen in isopentane. Frozen sections
were cut (6-10 mm thick) at -16uC using a LEICA cryostat and
mounted with DAKO fluorescent mounting medium (DAKO).
The fluorescence of the ECFP was visualised using a Zeiss
LSM710 confocal.
FACS analysis of disaggregated SCC tumours
Tumours were established following injection of 16106
squamous cell carcinoma (SCC) cells into the flank of FVB
MacBlue mice. Tumours were removed from euthanized mice and
digested in DMEM supplemented with 2 mg/ml collagenase D for
1 hour at 37uC. Following centrifugation, cells were resuspended
in blood cell lysis buffer (Pharm Lysis Buffer, Becton Dickinson) for
5 minutes at 37uC. Cells were then resuspended in PBS and passed
through a 70 mm cell strainer and washed three times in FACS
buffer (PBS+1% FBS+0.1% sodium azide). Cells were placed
(16105 per well) in 96-well plates and cell pellets were resuspended
in 50 ml of Fc block (Fc antibody (eBioscience) and incubated for
15 minutes at 4uC. 50 ml of antibody mixture (CD45 e780,
aCD11b PE, and F4/80, all 1:200) was added and samples
incubated for 30 mins in the dark at 4uC. The plate was then
centrifuged and the cells resuspended in FACS buffer for a total of
3 washes before analysis using a BD FACS Aria II. Data analysis
was performed using FlowJo software.
Intravital imaging
To enable intra-vital imaging of macrophage infiltration into
tumours, a Green Fluorescent Protein (GFP) labelled tumour
fragment was implanted as previously described under a dorsal
skinfold window [38] on a MacBlue mouse and images acquired 9
days post-implantation. Briefly, tumours were first established by
subcutaneous injection of GFP-expressing SCC cells [37] into the
flank of an FVB mouse. After approximately 7 days the resulting
tumour was removed from the euthanized host and small
fragments of approximately 1 mm were implanted under a dorsal
skinfold chamber that had been surgically installed onto an FVB
MacBlue mouse using a surgical procedure previously described
[38]. To enable high-resolution confocal imaging the mouse was
anesthetized by isoflurane inhalation, placed on a custom built
heated microscope stage, and the dorsal skinfold chamber
mechanically clamped onto the stage. Images were acquired using
an Olympus FV1000 confocal microscope equipped with a
LUMPLFLN 40XW 0.8 N.A. water immersion objective lens.
ECFP was imaged using a 405 nm laser line and GFP using a
488 nm laser line. Images were acquired using sequential scanning
to avoid spectral bleed through from ECFP into the GFP detection
channel.
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Imaging nasal-associated lymphoid tissue
The nasal-associated lymphoid tissue (NALT) was removed for
analysis by first dislocating and removing the lower jaw. After
removing cheek muscles, cheek bones and back teeth, the
remaining nose part contained the nasal turbinates, septum,
lateral walls, and palate. NALT was separated from the rest of the
nasal tissue by peeling away gently from the palate and whole-
mounted onto microscope slides with DAKO fluorescent mount-
ing medium. The oesophagus was carefully excised from the throat
and cut open laterally. After gently washing with PBS, the
oesophagus was wholemounted onto microscope slides with
DAKO fluorescent mounting medium. All tissues were imaged
using LSM710 confocal microscope.
Supporting Information
Figure S1 The expression of MacBlue transgenes in
nasal-associated lymphoid tissue. The oesophagus was
excised from MacBlue mice and ECFP expression examined in
the submucosa (A) and muscularis (B). The nasal-associated
lymphoid tissue was also examined (C).
(TIF)
Figure S2 The expression of MacBlue transgenes in
dendritic cell populations of the gut. Small intestinal,
colonic and mesenteric lymph node isolates from MacBlue mice
were obtained by enzymatic digest and analysed using multi-
parameter flow cytometry. Live CD45+CD11c+MHCII+F4/802
cells from small intestine (A) and colon (B) were split into 4 regions
based on CD103 and CD11b expression and ECFP expression
examined. (C) Cells were isolated from mesenteric lymph nodes by
enzymatic digestion and resident DC (MHCint/+) and migratory
DC (MHChi) were examined for ECFP expression.
(TIF)
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